1
|
Koechlin L, Boeddinghaus J, Lopez-Ayala P, Nestelberger T, Wussler D, Twerenbold R, Zimmermann T, Wildi K, Miro O, Martin-Sanchez J, Keller D, Christ M, Buser A, Rubini Gimenez M, Mueller C. 0/1h-algorithm using a new high-sensitivity cardiac troponin I assay for early diagnosis of myocardial infarction. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The clinical performance of the novel high-sensitivity cardiac troponin I EXL (hs-cTnI-EXL) assay is unknown so far.
Purpose
We aimed to validate the clinical performance of the hs-cTnI-EXL assay and to derive and validate an hs-cTnI-EXL-specific 0/1h-algorithm for the early diagnosis of myocardial infarction (MI).
Methods
This multicenter study included patients presenting to the emergency department with symptoms suggestive of myocardial infarction. Central adjudication of final diagnoses was performed by two independent cardiologists using all clinical information including cardiac imaging twice: first, using serial hs-cTnI-Architect (primary analysis) and second, using serial hs-cTnT-Elecsys (secondary analysis) concentrations in addition to those clinically used (hs)-cTn. Hs-cTnI-EXL was measured at presentation and at 1h. The primary objective was to directly compare diagnostic accuracy quantified by the area under the receiver-operating-characteristic curve (AUC) of hs-cTnI-EXL, hs-cTnI-Architect and hs-cTnT-Elecsys. Secondary objectives included the derivation and validation of an hs-cTnI- EXL-specific 0/1h-algorithm.
Results
MI was the adjudicated final diagnosis in 204/1454 (14%) patients. At presentation, the AUC for hs-cTnI-EXL was 0.94 (95% CI, 0.93–0.96), being comparable to hs-cTnI-Architect (0.95; 95% CI, 0.93–0.96) and hs-cTnT-Elecsys (0.93; 95% CI, 0.91–0.95; Figure 1). In the derivation cohort (n=813), an optimal hs-cTnI-EXL-0/1h-algorithm was rule-out of MI with <9ng/L if onset of chest pain >3h or <9ng/L & 0h-1h-change <5ng/L, and rule-in with ≥160ng/L or 0h-1h-change ≥100ng/L. In the validation cohort (n=345), this hs-cTnI-EXL-0/1h-algorithm also performed well: rule-out in 56% of patients, negative predictive value 99.5% (95% CI, 97.1–99.9), sensitivity 97.8% (95% CI, 88.7–99.6), rule-in in 9% of patients, positive predictive value 83.3% (95% CI, 66.4–92.7), specificity 98.3% (95% CI, 96.1–99.3; Figure 2). Secondary analyses confirmed the findings using adjudication including serial measurements of hs-cTnT-Elecsys.
Conclusions
Hs-cTnI-EXL has comparable diagnostic performance to the currently best-validated hs-cTnT/I assays.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Swiss National Foundation, Swiss Heart Foundation
Collapse
Affiliation(s)
- L Koechlin
- University Hospital Basel , Basel , Switzerland
| | | | | | | | - D Wussler
- University Hospital Basel , Basel , Switzerland
| | - R Twerenbold
- University Medical Center Hamburg Eppendorf, University Center of Cardiovascular Science & Department of Cardiology , Hamburg , Germany
| | | | - K Wildi
- University Hospital Basel , Basel , Switzerland
| | - O Miro
- Hospital Clinic de Barcelona , Barcelona , Spain
| | - J Martin-Sanchez
- Hospital Clinico San Carlos, Servicio de Urgencias , Madrid , Spain
| | - D Keller
- University Hospital Zurich, Emergency Department , Zurich , Switzerland
| | - M Christ
- Kantonsspital Lucerne, Emergency Department , Lucerne , Switzerland
| | - A Buser
- University Hospital Basel , Basel , Switzerland
| | - M Rubini Gimenez
- Heart Center of Leipzig, Department of Cardiology , Leipzig , Germany
| | - C Mueller
- University Hospital Basel , Basel , Switzerland
| |
Collapse
|
2
|
De Vooght KMK, Lozano M, Bueno JL, Alarcón A, Romera I, Suzuki K, Zhiburt E, Holbro A, Infanti L, Buser A, Hustinx H, Deneys V, Frélik A, Thiry C, Murphy M, Staves J, Selleng K, Greinacher A, Kutner JM, Bonet Bub C, Castilho L, Kaufman RM, Colling ME, Perseghin P, Incontri A, Dassi M, Brilhante D, Macédo A, Cserti-Gazdewich C, Pendergrast JM, Hawes J, Lundgren MN, Storry JR, Jain A, Marwaha N, Sharma RR. International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy. Vox Sang 2018; 113. [PMID: 29947125 DOI: 10.1111/vox.12652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
| | | | - J-L Bueno
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - A Alarcón
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - I Romera
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - K Suzuki
- Department of Internal Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan
| | - E Zhiburt
- Blood Transfusion Department, Pirogov Russian National Medical Surgical Center, 70, Nizhnyaya Pervomaiskaya ul, Moscow, 105203, Russia
| | - A Holbro
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - L Infanti
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - A Buser
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - H Hustinx
- National Reference Laboratory, Swiss Blood Transfusion Service, Interregional Blood Transfusion Service SRC Ltd, Murtenstrasse 133, Bern, 3008, Switzerland
| | - V Deneys
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - A Frélik
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - C Thiry
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - M Murphy
- NHS Blood & Transplant, Oxford University Hospitals, NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
| | - J Staves
- Oxford University Hospitals, NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
| | - K Selleng
- Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstr, Greifswald, 17475, Germany
| | - A Greinacher
- Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstr, Greifswald, 17475, Germany
| | - J M Kutner
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - C Bonet Bub
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - L Castilho
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - R M Kaufman
- Brigham and Women's Hospital, Blood Bank, Amory 260, 75 Francis Street, Boston, MA, 02115, USA
| | - M E Colling
- Brigham and Women's Hospital, Blood Bank, Amory 260, 75 Francis Street, Boston, MA, 02115, USA
| | - P Perseghin
- Laboratorio di Criobiologia, UOS Aferesi e nuove tecnologie trasfusionali, ASST-Monza Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - A Incontri
- Laboratorio di Immunoematologia, UOS Aferesi e nuove tecnologie trasfusionale, ASST-Monza, Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - M Dassi
- Laboratorio di Immunoematologia, UOS Aferesi e nuove tecnologie trasfusionale, ASST-Monza, Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - D Brilhante
- Serviço de Imunohemoterapia, Instituto Português de Oncologia Lisboa Francisco Gentil, EPE, Lisboa, Portugal
| | - A Macédo
- Serviço de Imunohemoterapia, Instituto Português de Oncologia Lisboa Francisco Gentil, EPE, Lisboa, Portugal
| | - C Cserti-Gazdewich
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - J M Pendergrast
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - J Hawes
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - M N Lundgren
- Deparment of Clinical Immunology and Transfusion Medicine, Labmedicin Skane, Akutgatan 8, Lund, SE-22185, Sweden
| | - J R Storry
- Deparment of Clinical Immunology and Transfusion Medicine, Labmedicin Skane, Akutgatan 8, Lund, SE-22185, Sweden
| | - A Jain
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| | - N Marwaha
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| | - R R Sharma
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| |
Collapse
|
3
|
de Vooght KMK, Lozano M, Bueno JL, Alarcón A, Romera I, Suzuki K, Zhiburt E, Holbro A, Infanti L, Buser A, Hustinx H, Deneys V, Frélik A, Thiry C, Murphy M, Staves J, Selleng K, Greinacher A, Kutner JM, Bonet Bub C, Castilho L, Kaufman R, Colling ME, Perseghin P, Incontri A, Dassi M, Brilhante D, Macêdo A, Cserti-Gazdewich C, Pendergrast JM, Hawes J, Lundgren MN, Storry JR, Jain A, Marwaha N, Sharma RR. Vox Sanguinis International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy: summary. Vox Sang 2018; 113:492-498. [PMID: 29781081 DOI: 10.1111/vox.12653] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- K M K de Vooght
- Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - M Lozano
- Department of Hemotherapy and Hemostasis, University Clinic Hospital, University of Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Mauramo M, Ramseier AM, Mauramo E, Buser A, Tervahartiala T, Sorsa T, Waltimo T. Associations of oral fluid MMP-8 with periodontitis in Swiss adult subjects. Oral Dis 2017; 24:449-455. [PMID: 28889479 DOI: 10.1111/odi.12769] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2017] [Revised: 08/06/2017] [Accepted: 08/22/2017] [Indexed: 12/20/2022]
Abstract
OBJECTIVE MMP-8 is a prominent collagenase in periodontal disease. This cross-sectional study examined whether MMP-8 levels in saliva and gingival crevicular fluid (GCF) are associated with periodontitis in a Swiss population. SUBJECTS AND METHODS A total of 258 subjects (107 m, 151 f, mean age: 43.5 yr; range: 21-58 yr) acquired from the Swiss bone marrow donor registry participated in the study. Saliva and GCF samples were collected from subjects followed by a thorough dental and periodontal examination. MMP-8 levels were determined with immunofluorometric assay. Associations of MMP-8 levels with periodontal diagnosis, probing pocket depth (PPD) and bleeding on probing were statistically analysed with Pearson chi-square test, Spearman's rho and logistic regression analysis. RESULTS MMP-8 in GCF correlated with MMP-8 in saliva (p < .001). Periodontitis was more common (p < .001) among subjects with high levels of MMP-8 in saliva and/or GCF compared with subjects with low levels of MMP-8. Higher MMP-8 levels in GCF and saliva were associated with any periodontal diagnosis (mild, moderate or severe), greater PPD, and bleeding on probing (p < .05). When age, gender, smoking, body mass index, number of medications and decayed, missing and filled teeth were adjusted for, all observed associations remained statistically significant. The area under curve of receiver-operating characteristic was 0.67 for saliva and 0.71 for GCF. CONCLUSION Elevated MMP-8 levels both in saliva and GCF are associated with periodontitis in a normal adult population.
Collapse
Affiliation(s)
- M Mauramo
- Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.,Department of Pathology, Haartman Institute and HUSLab, Helsinki University Central Hospital, Helsinki, Finland
| | - A M Ramseier
- Department of Preventive Dentistry and Oral Microbiology, School of Dental Medicine, University of Basel, Basel, Switzerland
| | - E Mauramo
- Department of Public Health, University of Helsinki, Helsinki, Finland
| | - A Buser
- The Blood Transfusion Service SRC Basel, Basel, Switzerland
| | - T Tervahartiala
- Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - T Sorsa
- Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.,Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden
| | - T Waltimo
- Department of Preventive Dentistry and Oral Microbiology, School of Dental Medicine, University of Basel, Basel, Switzerland
| |
Collapse
|
5
|
Cohn C, Dumont L, Lozano M, Marks D, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama A, Kutner J, Acker J, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun P, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer P, de Korte D, Wagner S, O'Neill M. Vox Sanguinis International Forum on platelet cryopreservation. Vox Sang 2017; 112:e69-e85. [DOI: 10.1111/vox.12532] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
| | | | | | - D.C. Marks
- Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - L. Johnson
- Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - S. Ismay
- Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - N. Bondar
- Australian Red Cross Blood Service; 17 O'Riordan Street Alexandria NSW 2015 Australia
| | - F. T'Sas
- HMRA - Service Militaire de Transfusion Sanguine; Rue Bruyn 1 1120 Bruxelles Belgique
| | - A.P.H. Yokoyama
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Av. Albert Einstein, 627 Sao Paulo SP 05651-901 Brazil
| | - J.M. Kutner
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Av. Albert Einstein, 627 Sao Paulo SP 05651-901 Brazil
| | - J.P. Acker
- Canadian Blood Services; 8249-114 Street Edmonton AB T6G 2R8 Canada
| | - M. Bohonek
- Department of Hematology and Blood Transfusion; Military University Hospital Prague; U Vojenske nemocnice 1200 Prague 169 02 Czech Republic
| | - A. Sailliol
- French Military Blood Institute; 1 rue de Lieutenant Batany Clamart 92140 France
| | - C. Martinaud
- French Military Blood Institute; 1 rue de Lieutenant Batany Clamart 92140 France
| | - R. Pogłód
- Zakład Transfuzjologii; Instytut Hematologii i Transfuzjologii; ul. I. Gandhi 14 Warszawa 02-776 Poland
| | - J. Antoniewicz-Papis
- Institute of Hematology and Transfusion Medicine; Indiry Gandhi 14 Warsaw 02-776 Poland
| | - E. Lachert
- Institute of Hematology and Transfusion Medicine; Indiry Gandhi 14 Warsaw 02-776 Poland
| | - P.B.L. Pun
- Defence Medical & Environmental Research Institute; DSO National Laboratories (Kent Ridge); 27 Medical Drive Singapore 117510
| | - J. Lu
- Defence Medical & Environmental Research Institute; DSO National Laboratories (Kent Ridge); 27 Medical Drive Singapore 117510
| | - J. Cid
- Apheresis Unit; Department of Hemotherapy and Hemostasis; ICMHO; Hospital Clínic; Villarroel 170 Barcelona Catalonia 08036 Spain
| | - F. Guijarro
- Apheresis Unit; Department of Hemotherapy and Hemostasis; ICMHO; IDIBAPS; Hospital Clínic; University of Barcelona; Barcelona Spain
| | - L. Puig
- Banc de Sang i Teixits de Catalunya; Transfusion Safety Laboratory; Barcelona Spain
| | - B. Gerber
- Division of Hematology; Oncology Institute of Southern Switzerland; Bellinzona CH-6500 Switzerland
| | - L. Alberio
- Division of Hematology and Central Hematology Laboratory; CHUV; Lausanne University Hospital; Lausanne Switzerland
| | - U. Schanz
- Division of Hematology; University and University Hospital Zurich; Zurich Switzerland
| | - A. Buser
- Hematology; University Hospital Basel; Basel Switzerland
| | - F. Noorman
- Military Blood Bank; Plesmanlaan 1c 2333 BZ The Netherlands
| | - M. Zoodsma
- Military Blood Bank; Plesmanlaan 1c 2333 BZ The Netherlands
| | - P.F. van der Meer
- Department of Product and Process Development; Sanquin Blood Bank; Plesmanlaan 125 Amsterdam 1066 CX The Netherlands
| | - D. de Korte
- Sanquin Blood Bank North West Region; Plesmanlaan 125 Amsterdam 1066 CX The Netherlands
| | - S. Wagner
- Transfusion Innovation Dept.; American Red Cross Holland Lab; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - M. O'Neill
- American Red Cross Medical Office; 180 Rustcraft Rd Dedham MA 020206 USA
| |
Collapse
|
6
|
Cohn CS, Dumont LJ, Lozano M, Marks DC, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker JP, Bohonek M, Sailliol A, Martinaud C, Pogłód R, Antoniewicz-Papis J, Lachert E, Pun PBL, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M. Vox Sanguinis International Forum on platelet cryopreservation: Summary. Vox Sang 2017; 112:684-688. [PMID: 28929502 DOI: 10.1111/vox.12533] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- C S Cohn
- Department of Laboratory Medicine and Pathology, University of Minnesota, D242 Mayo Building, MMC 609, 420 Delaware Street SE, Minneapolis, MN, 55455, USA
| | - L J Dumont
- Blood Systems Research Institute Denver, 717 Yosemite Street, Denver, CO, 80230, USA
| | - M Lozano
- Department of Hemotherapy and Hemostasis, University Clinic Hospital, University of Barcelona, 08036, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Holbro A, Volken T, Buser A, Sigle JP, Halter JP, Passweg JR, Tichelli A, Infanti L. Iron deficiency and thrombocytosis. Vox Sang 2016; 112:87-92. [DOI: 10.1111/vox.12454] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2016] [Revised: 07/24/2016] [Accepted: 09/02/2016] [Indexed: 12/16/2022]
Affiliation(s)
- A. Holbro
- Division of Hematology; University Hospital Basel; Basel Switzerland
- Blood Transfusion Center; Swiss Red Cross; Basel Switzerland
| | - T. Volken
- School of Health Professions; Zurich University of Applied Sciences; Winterthur Switzerland
| | - A. Buser
- Division of Hematology; University Hospital Basel; Basel Switzerland
- Blood Transfusion Center; Swiss Red Cross; Basel Switzerland
| | - J. P. Sigle
- Blood Transfusion Center; Swiss Red Cross; Aarau Switzerland
| | - J. P. Halter
- Division of Hematology; University Hospital Basel; Basel Switzerland
| | - J. R. Passweg
- Division of Hematology; University Hospital Basel; Basel Switzerland
| | - A. Tichelli
- Division of Hematology; University Hospital Basel; Basel Switzerland
| | - L. Infanti
- Division of Hematology; University Hospital Basel; Basel Switzerland
- Blood Transfusion Center; Swiss Red Cross; Basel Switzerland
| |
Collapse
|
8
|
Goldman M, Magnussen K, Gorlin J, Lozano M, Speedy J, Keller A, Pink J, Leung JNS, Chu CCY, Lee CK, Faed J, Chay J, Tan HH, Teo D, Djoudi R, Woimant G, Fillet AM, Castrén J, Miflin G, Vandewalle GC, Compernolle V, Cardenas JM, Infanti L, Holbro A, Buser A, van den Hurk K, Yahalom VJ, Gendelman V, Shinar E, Eder AF, Steele WR, O'Neill EM, Kamel H, Vassallo R, Delage G, Lebrun A, Robillard P, Germain M, Gandhi M, West KA, Klein HG. International Forum regarding practices related to donor haemoglobin and iron. Vox Sang 2016; 111:449-455. [DOI: 10.1111/vox.12431] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- M. Goldman
- Medical Services and Innovation; Canadian Blood Services; Ottawa ON Canada
| | - K. Magnussen
- Clinical Immunology/Blood Centre; Copenhagen University Hospital; Hvidovre Denmark
| | - J. Gorlin
- Physician Services; Innovative Blood Centers; St. Paul MN USA
| | - M. Lozano
- Hospital Clinic; Department of Hemotherapy and Hemostasis; Barcelona Spain
| | - J. Speedy
- Australian Red Cross Blood Service; Adelaide South Australia Australia
| | - A. Keller
- Australian Red Cross; Perth Western Australia Australia
| | - J. Pink
- Australian Red Cross Blood Service; Stafford Queensland Australia
| | - J. N. S. Leung
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - C. C. Y. Chu
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - C.-K. Lee
- Blood Collection and Donor Recruitment Department; Hong Kong Red Cross Blood Transfusion Service; Kowloon Hong Kong
| | - J. Faed
- Otago Site, New Zealand Blood Service; Department of Haematology; University of Otago; Dunedin New Zealand
| | - J. Chay
- Blood Services Group; Health Sciences Authority; 11 Outram Road Singapore City 169078 Singapore
| | - H. H. Tan
- Blood Services Group; Health Sciences Authority; 11 Outram Road Singapore City 169078 Singapore
| | - D. Teo
- Centre for Transfusion Medicine; Singapore City Singapore
| | - R. Djoudi
- Qualification Biologique du Don; Etablissement Français du Sang; St. Denis France
| | - G. Woimant
- EFS, Médecine, la Recherche et l'Innovation; La Plaine Saint-Denis France
| | - A.-M. Fillet
- Medical Department; Etablisement Français du Sang; 20 Avenue du Stade de France La Plaine Saint-Denis 93218 France
| | - J. Castrén
- Medical Support in Blood Donation; Finnish Red Cross Blood Service; Kivihaantie 7 Helsinki FI-00310 Finland
| | - G. Miflin
- NHS Blood and Transplant; Watford UK
| | | | - V. Compernolle
- Blood Services; Belgian Red Cross; Ottergemsesteenweg 413 Ghent B-9000 Belgium
| | - J. M. Cardenas
- Tejidos Humanos; Centro Vasco de Transfusion y Tejidos Humanos; Labeaga s/n Galdakao 48960 Spain
| | - L. Infanti
- Blood Donation Center; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
| | - A. Holbro
- Blood Transfusion Centre; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
- Department of Hematology; University Hospital Basel; Basel Switzerland
| | - A. Buser
- Blood Transfusion Centre; Swiss Red Cross; Hebelstrasse 10 Basel CH-4031 Switzerland
- Department of Hematology; University Hospital Basel; Basel Switzerland
| | - K. van den Hurk
- Donor Studies; Sanquin Research; Plesmanlaan 125 Amsterdam 1066 CX The Netherlands
| | - V. J. Yahalom
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - V. Gendelman
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - E. Shinar
- National Blood Services; Magen David Adom-National Blood Services; Ramat Gan 5262100 Israel
| | - A. F. Eder
- Biomedical Headquarters; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - W. R. Steele
- Transmissible Disease Department; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - E. M. O'Neill
- National Headquarters; Biomedical Services; American Red Cross; 15601 Crabbs Branch Way Rockville MD 20855 USA
| | - H. Kamel
- Medical Affairs; Blood Systems, Inc.; 6210 E. Oak Street Scottsdale AZ 85257 USA
| | - R. Vassallo
- Blood Systems, Inc.; 6210 E. Oak Street Scottsdale AZ 85257 USA
| | - G. Delage
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - A. Lebrun
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - P. Robillard
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - M. Germain
- Medical Affairs; Héma-Quebec; 4045 boul. Cote-Vertu, Ville Saint-Laurent Montreal QC Canada
| | - M. Gandhi
- Laboratory of Medicine and Pathology; Mayo Clinic Minnesota; 200 1st Street SW Rochester MN 55905 USA
| | - K. A. West
- Department of Transfusion Medicine; National Institutes of Health Clinical Center; 10 Center Drive, Room 1N226 Bethesda MD 20892 USA
| | - H. G. Klein
- Department of Transfusion Medicine; National Institute of Health; Warren G. Magnuson Clinical Center; 10 Center Drive, Room IC711 Bethesda MD 20892 USA
| |
Collapse
|
9
|
Medinger M, Krenger W, Jakab A, Halter J, Buser A, Bucher C, Passweg J, Tzankov A. Numerical impairment of nestin(+) bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML. Bone Marrow Transplant 2015; 50:1453-8. [PMID: 26301968 DOI: 10.1038/bmt.2015.189] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Revised: 06/25/2015] [Accepted: 07/10/2015] [Indexed: 01/12/2023]
Abstract
The nestin(+) perivascular bone marrow (BM) stem cell niche (N(+)SCN) may be involved in GvHD. To investigate whether acute GvHD (aGvHD) reduces the number of N(+)SCN, we examined patients with AML who had undergone allogeneic hematopoietic stem cell transplantation. In the test cohort (n=8), the number of N(+)SCN per mm(2) in BM biopsies was significantly reduced in aGvHD patients at the time of aGvHD compared with patients who did not have aGvHD (1.2±0.78 versus 2.6±0.93, P=0.04). In the validation cohort (n=40), the number of N(+)SCN was reduced (1.9±0.99 versus 2.6±0.90 N(+)SCN/mm(2), P=0.05) in aGvHD patients. Receiver operating curves suggested that the cutoff score that best discriminated between patients with and without aGvHD was 2.29 N(+)SCN/mm(2). Applying this cutoff score, 9/11 patients with clinically relevant aGvHD (⩾grade 2) and 13/20 with any type of GvHD had decreased N(+)SCN numbers compared with only 10/29 patients without clinically relevant aGvHD (P=0.007) and 6/20 patients without any type of GvHD (P=0.028). In patients tracked over time, N(+)SCN density returned to normal after aGvHD resolved or remained stable in patients who did not have aGvHD. Our results show a decrease in the number of N(+)SCN in aGvHD.
Collapse
Affiliation(s)
- M Medinger
- Hematology, University Hospital Basel, Basel, Switzerland
| | - W Krenger
- GMP Facility, University Hospital Basel, Basel, Switzerland
| | - A Jakab
- Hematology, University Hospital Basel, Basel, Switzerland
| | - J Halter
- Hematology, University Hospital Basel, Basel, Switzerland
| | - A Buser
- Hematology, University Hospital Basel, Basel, Switzerland
| | - C Bucher
- Hematology, University Hospital Basel, Basel, Switzerland
| | - J Passweg
- Hematology, University Hospital Basel, Basel, Switzerland
| | - A Tzankov
- Institute of Pathology, University Hospital Basel, Basel, Switzerland
| |
Collapse
|
10
|
Volken T, Buser A, Holbro A, Bart T, Infanti L. Blood donor to inactive donor transition in the Basel region between 1996 and 2011: a retrospective cohort study. Vox Sang 2015; 109:155-62. [DOI: 10.1111/vox.12269] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2014] [Revised: 02/07/2015] [Accepted: 02/09/2015] [Indexed: 11/28/2022]
Affiliation(s)
- T. Volken
- School of Health Professions; Zurich University of Applied Sciences; Winterthur Switzerland
| | - A. Buser
- Regional Blood Transfusion Service; Swiss Red Cross; Basel Switzerland
| | - A. Holbro
- Regional Blood Transfusion Service; Swiss Red Cross; Basel Switzerland
| | - T. Bart
- Swiss Transfusion SRC; Bern Switzerland
| | - L. Infanti
- Regional Blood Transfusion Service; Swiss Red Cross; Basel Switzerland
| |
Collapse
|
11
|
Osselaer J, Buser A, Tissot J, Cazenave J. Dix ans d’expérience d’inactivation des agents pathogènes par INTERCEPT : données d’hémovigilance. Transfus Clin Biol 2014. [DOI: 10.1016/j.tracli.2014.08.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
12
|
Buser A. Objektive Refraktionsbestimmung – Skiaskopie. Augenheilkunde up2date 2014. [DOI: 10.1055/s-0033-1357959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- A. Buser
- Hochschule Aalen, Studiengang Augenoptik, Aalen
| |
Collapse
|
13
|
Buser A. Objektive Refraktionsbestimmung – Skiaskopie. Klin Monbl Augenheilkd 2014; 231:841-55; quiz 856-8. [DOI: 10.1055/s-0033-1357960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- A. Buser
- Hochschule Aalen, Studiengang Augenoptik, Aalen
| |
Collapse
|
14
|
Baumbach P, Buser A. Grundlagen der Optik. Augenheilkunde up2date 2013. [DOI: 10.1055/s-0032-1325079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
| | - A. Buser
- Hochschule Aalen, Studiengang Augenoptik
| |
Collapse
|
15
|
Stefashyna O, Stern M, Infanti L, Holbro A, Tichelli A, Buser A, O'Meara A. Pattern of care of blood donors with early-uncomplicated hereditary haemochromatosis in a Swiss blood donation centre. Vox Sang 2013; 106:111-7. [DOI: 10.1111/vox.12078] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2013] [Revised: 07/27/2013] [Accepted: 08/05/2013] [Indexed: 12/27/2022]
Affiliation(s)
- O. Stefashyna
- Blood Transfusion Centre; Swiss Red Cross; Basel Switzerland
| | - M. Stern
- Hematology; University Hospital; Basel Switzerland
| | - L. Infanti
- Blood Transfusion Centre; Swiss Red Cross; Basel Switzerland
| | - A. Holbro
- Blood Transfusion Centre; Swiss Red Cross; Basel Switzerland
| | - A. Tichelli
- Hematology; University Hospital; Basel Switzerland
| | - A. Buser
- Blood Transfusion Centre; Swiss Red Cross; Basel Switzerland
| | - A. O'Meara
- Hematology; University Hospital; Basel Switzerland
| |
Collapse
|
16
|
Baumbach P, Buser A. Grundlagen der Optik. Klin Monbl Augenheilkd 2013; 230:745-64; quiz 765-7. [DOI: 10.1055/s-0032-1325080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
| | - A. Buser
- Hochschule Aalen, Studiengang Augenoptik
| |
Collapse
|
17
|
Sigle JP, Thierbach J, Infanti L, Muriset M, Hunziker G, Chassot K, Niederhauser C, Gowland P, Holbro A, Sunic K, Buser A, Fontana S. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention. Vox Sang 2013; 105:244-52. [DOI: 10.1111/vox.12045] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2012] [Revised: 03/29/2013] [Accepted: 03/29/2013] [Indexed: 12/01/2022]
Affiliation(s)
| | - J. Thierbach
- Regional Blood Transfusion Service of the Swiss Red Cross; St. Gallen; Switzerland
| | - L. Infanti
- Regional Blood Transfusion Service of the Swiss Red Cross; Basel; Switzerland
| | - M. Muriset
- Regional Blood Transfusion Service of the Swiss Red Cross; Bern; Switzerland
| | - G. Hunziker
- Regional Blood Transfusion Service of the Swiss Red Cross; Basel; Switzerland
| | - K. Chassot
- Regional Blood Transfusion Service of the Swiss Red Cross; Basel; Switzerland
| | - C. Niederhauser
- Regional Blood Transfusion Service of the Swiss Red Cross; Bern; Switzerland
| | - P. Gowland
- Regional Blood Transfusion Service of the Swiss Red Cross; Bern; Switzerland
| | - A. Holbro
- Regional Blood Transfusion Service of the Swiss Red Cross; Basel; Switzerland
| | - K. Sunic
- Regional Blood Transfusion Service of the Swiss Red Cross; St. Gallen; Switzerland
| | - A. Buser
- Regional Blood Transfusion Service of the Swiss Red Cross; Basel; Switzerland
| | - S. Fontana
- Regional Blood Transfusion Service of the Swiss Red Cross; Bern; Switzerland
| |
Collapse
|
18
|
Charoudeh HN, Schmitter K, Buser A, Gonzalez A, Stern M. A polymorphism affecting HLA-C surface expression associates with herpes simplex virus and cytomegalovirus immunoglobulin G seropositivity. ACTA ACUST UNITED AC 2012; 80:263-4. [PMID: 22703169 DOI: 10.1111/j.1399-0039.2012.01913.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
19
|
Bazuaye GN, Buser A, Gerull S, Tichelli A, Stern M. Erratum: Prognostic impact of iron parameters in patients undergoing allo-SCT. Bone Marrow Transplant 2012. [DOI: 10.1038/bmt.2012.47] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
20
|
Khanlari B, Buser A, Lugli A, Tichelli A, Dirnhofer S. The Expression Pattern of CD56 (N-CAM) in Human Bone Marrow Biopsies Infiltrated by Acute Leukemia. Leuk Lymphoma 2011; 44:2055-9. [PMID: 14959847 DOI: 10.1080/1042819031000119307] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
In hematological neoplasms CD56 (N-CAM) is expressed by T/natural killer (NK) cell lymphoma, by most neoplastic plasma cells in multiple myeloma and also in a subset of acute myelogenous leukemias (AML). In the latter, it is an indicator of poor clinical outcome. Most of the data on CD56 expression in acute leukemia have been obtained by flow cytometric analysis. Up to now, no systematic analysis of the expression pattern of CD56 in formalin fixed paraffin embedded bone marrow biopsies of acute leukemias has been performed. We immunohistochemically studied the expression of CD56 in a series of 141 bone marrow biopsies fixed in Sublimat Mercury II Chloride (SUSA) including 100 cases of AML FAB M0-M7, 11 cases of AML not further specified, 3 cases of biphenotypical leukemia, 20 cases of acute lymphoblastic leukemia (ALL) and 7 cases of reactive bone marrow biopsies. Overall, 14 of 134 (10%) leukemia cases were positive for CD56. Detail analysis revealed positivity in 5/13 cases of AML M5 (38%), 3/9 AML M1 (33%), 1/8 AML M0 (13%), 1/11 AML not specified (9%), 2/31 AML M2 (7%) and 2/26 AML M4 (8%). All cases of ALL and biphenotypic leukemias were CD56 negative. The CD56 expression in AML M5 was statistically significant (p = 0.003). On paraffin embedded bone marrow biopsies CD56 expression occurs in de novo AML with an overall frequency of 13%. It is significantly correlated with AML M5, which is positive in 38% of the cases. Cases of ALL are consistently CD56 negative.
Collapse
Affiliation(s)
- B Khanlari
- Institute of Pathology, University Hospital Basel, Schoenbeinstrasse 40, 4031 Basel, Switzerland
| | | | | | | | | |
Collapse
|
21
|
Pittori C, Buser A, Gasser UE, Sigle J, Job S, Rüesch M, Tichelli A, Infanti L. A pilot iron substitution programme in female blood donors with iron deficiency without anaemia. Vox Sang 2010; 100:303-11. [PMID: 21091697 DOI: 10.1111/j.1423-0410.2010.01427.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
BACKGROUND AND OBJECTIVES Blood donation can contribute to iron deficiency. The possibly resulting anaemia importantly affects donor return rate. The determination of serum ferritin levels revealed iron deficiency in many non-anaemic premenopausal female blood donors at our Institution. We started an iron substitution programme targeting this donor group to prevent anaemia and enhance donor retain. MATERIALS AND METHODS Women aged≤50 with haemoglobin levels adequate for donation and serum ferritin≤10 ng/ml were offered iron supplementation. Substitution lasted 16 weeks and the donation interval was extended. History collection including iron deficiency-related symptoms, whole blood count and serum ferritin determination was performed at baseline and after 2 and 6 months. Data were recorded prospectively and compared with those of 108 female controls with iron deficiency not receiving iron substitution (retrospective data). RESULTS Of the 116 participating subjects, 60% completed the programme. Significant results were serum ferritin increase (from a mean value of 7.12 to 25.2 ng/ml), resolution of prostration, fatigue, sleep disturbances, tension in the neck, hair loss and nail breakage. No case of anaemia occurred. Sixty per cent of the women completed the programme and donated blood again. CONCLUSIONS Targeted iron substitution prevents the development of anaemia and enhances donation return in premenopausal female blood donors with iron deficiency.
Collapse
Affiliation(s)
- C Pittori
- Blood Transfusion Centre, Swiss Red Cross, Basel, Switzerland
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Worel N, Panzer S, Reesink HW, Linkesch W, Dickmeiss E, Fischer-Nielsen A, Hölig K, Stachel D, Zimmermann R, Holter W, Coluccia P, Brilhante D, Watz E, Sigle JP, Gratwohl A, Buser A, Arslan O, Regan F, Edwards M. Transfusion policy in ABO-incompatible allogeneic stem cell transplantation. Vox Sang 2010; 98:455-67. [DOI: 10.1111/j.1423-0410.2009.01292.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
23
|
Buser A, Stern M, Arber C, Medinger M, Halter J, Rovo A, Favre G, Lohri A, Tichelli A, Gratwohl A. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab? Bone Marrow Transplant 2008; 42:483-7. [DOI: 10.1038/bmt.2008.229] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
24
|
Stern M, Halter J, Buser A, Rovò A, Dirnhofer S, Häusermann P. Leukemia cutis preceding systemic relapse of acute myeloid leukemia. Int J Hematol 2008; 87:108-109. [PMID: 18301961 DOI: 10.1007/s12185-008-0046-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2007] [Revised: 01/12/2008] [Accepted: 02/06/2008] [Indexed: 10/22/2022]
Affiliation(s)
- M Stern
- Department of Hematology, University Hospital, CH-Basel, Switzerland.
| | - J Halter
- Department of Hematology, University Hospital, CH-Basel, Switzerland
| | - A Buser
- Department of Hematology, University Hospital, CH-Basel, Switzerland
| | - A Rovò
- Department of Hematology, University Hospital, CH-Basel, Switzerland
| | - S Dirnhofer
- Department of Pathology, University Hospital, CH-Basel, Switzerland
| | - P Häusermann
- Department of Dermatology, University Hospital, CH-Basel, Switzerland
| |
Collapse
|
25
|
Arber C, Buser A, Heim D, Weisser M, Tyndall A, Tichelli A, Passweg J, Gratwohl A. Septic polyarthritis with Ureaplasma urealyticum in a patient with prolonged agammaglobulinemia and B-cell aplasia after allogeneic HSCT and rituximab pretreatment. Bone Marrow Transplant 2007; 40:597-8. [PMID: 17618319 DOI: 10.1038/sj.bmt.1705766] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
26
|
Morf LS, Taverna R, Buser A. Ressourcen- und Schadstoffmanagement in der Abfallwirtschaft: Die steigende Bedeutung der Recyclingprozesse am Beispiel der bromierten Flammschutzmittel. ACTA ACUST UNITED AC 2007. [DOI: 10.1007/s00506-006-0097-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
27
|
Martinez MT, Bucher C, Stussi G, Heim D, Buser A, Tsakiris DA, Tichelli A, Gratwohl A, Passweg JR. Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 2005; 36:993-1000. [PMID: 16184183 DOI: 10.1038/sj.bmt.1705160] [Citation(s) in RCA: 65] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
We studied occurrence, risk factors and outcome of patients with transplant-associated microangiopathy (TAM) after allogeneic stem cell transplantation (HSCT). A total of 221 consecutive patients were transplanted between 1995 and 2002. TAM is defined as evidence of hemolysis and schistocytes in the first 100 days. Outcomes analyzed included TAM and overall survival. Of 221 patients, 68 had TAM. The cumulative incidence was 31 (25-38)% at 100 days. Patients with TAM had higher LDH, higher bilirubin, higher creatinine and more often neurologic symptoms. TAM was not associated with stem cell source, cyclosporine levels and was not more frequent in recent years. In multivariate analysis, risk factors for TAM included donor type, age, gender, ABO-incompatibility and acute graft-versus-host disease (aGvHD). In patients with TAM, 1-year survival was lower than in patients without TAM (27 +/- 18% for TAM with high schistocyte counts; 53 +/- 15% for TAM with low schistocyte counts; vs 78 +/- 7% in patients without TAM; P<0.0001). TAM was independently associated with mortality adjusting for donor type, age and aGvHD occurrence and severity. TAM is frequent after HSCT and is associated with mortality even after adjustment for aGvHD grade. Risk factors of TAM are similar to aGvHD. TAM may represent endothelial damage driven by donor-host interactions.
Collapse
Affiliation(s)
- M T Martinez
- Hematology Division, Basel University Hospitals, Switzerland
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Sawatzki M, Hatz C, Buser A, Battegay M. Status febrilis mit Bewusstlosigkeit. Internist (Berl) 2005; 46:202-5. [PMID: 15657721 DOI: 10.1007/s00108-004-1337-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Cerebral malaria with Plasmodium vivax is uncommon. Normally Plasmodium falciparum is the cause of cerebral malaria. We report about a 18 year old patient from Pakistan with a history of intermittent fever for several months. The patient recovered within a few days; however prognosis can be severe when cerebral malaria is complicating the course of Plasmodium vivax infection.
Collapse
Affiliation(s)
- M Sawatzki
- Medizinische Klinik B, Universitätsspital Basel, Schweiz
| | | | | | | |
Collapse
|
29
|
Abstract
BACKGROUND This study was carried out to investigate the relationship between the frequency of traffic accidents and impaired vision. MATERIALS AND METHODS Seven hundred and fifty-four drivers involved in accidents were recruited, in addition to 250 accident-free drivers similar in age and driving experience as an control group. The age distribution of the persons involved in traffic accidents (mean 56.3 years) was similar to that of the control group (mean 57.7 years), the difference was not statistically significant. Both groups underwent a complete ophthalmological examination. RESULTS All three types of accidents (night-time accidents, violations of right of way, accidents during an overtaking manoeuvre) had a statistically significantly higher incidence of reduced photopic visual acuity, mesopic vision and an increased sensitivity to glare. Some other visual functions were also abnormal, with differences according to the type of accident. In particular, there were noticeable differences between the control group and those who were involved in night-time accidents regarding mesopic vision and sensitivity to glare. Concerning mesopic vision, 15% of the 261 persons involved in night-time accidents did not reach the contrast limit of 1:5; with glare, 20.7% failed. In comparison 4% of the control group reached this critical limit without glare and 7.6% with glare. These differences are highly statistically significant. In contrast to these findings, many of the drivers involved in accidents assessed their own visual capability as "excellent". CONCLUSIONS The results of this study show that reduced mesopic vision and increased sensitivity to glare are accompanied by an increased risk of night-time accidents (for example, collisions with a non-illuminated obstacle). This emphasizes the importance of regular ophthalmological check-ups including visual functions such as mesopic vision and sensitivity to glare, which currently are not required by the traffic laws in Germany.
Collapse
Affiliation(s)
- B Lachenmayr
- Institut für Mathematik und Datenverarbeitung, Universitätskrankenhaus Eppendorf, Hamburg
| | | | | | | |
Collapse
|
30
|
Abstract
Thyroid-associated ophthalmopathy (TAO) is evaluated mainly by orthoptic examination and morphometric parameters such as ultrasound, CT scanning or magnetic resonance imaging. Inflammatory changes of the extraocular muscles lead to an impairment of eye movement. Recent evidence suggests that saccades are altered by changes to the extraocular muscles. Although of potential interest, this phenomenon has so far received little attention. To determine the role of saccades as a potential diagnostic tool for assessing the function of the affected muscles, we have begun to analyze saccadic parameters in patients with TAO. Preliminary results of this study are reported in the present paper. For registration of both horizontal and vertical eye movements, we used the "Ober-2-Apparatus," which uses the infrared technique. Horizontal and vertical saccades with an amplitude of 10 degrees were analyzed in 20 healthy persons and 30 patients suffering from TAO. Patients showed changes in the quality of saccades, such as the appearance of glissades and additional correctional saccades as well as quantitative changes, such as an increase in the maximum speed and latency. Our current data suggest the presence of saccadic alterations in TAO. Our ongoing studies are designed to evaluate whether characteristic changes can be assigned to certain stages of the disease and whether assessment of saccadic changes in a promising tool for early detection and functional follow-up in patients with TAO.
Collapse
Affiliation(s)
- H D Schworm
- Augenklinik, Klinikum Innenstadt, Ludwig-Maximilians-Universität München
| | | | | | | | | | | |
Collapse
|
31
|
Buser A, Lachenmayr B, Priemer F, Langnau A, Gilg T. [Effect of low alcohol concentrations on visual attention in street traffic]. Ophthalmologe 1996; 93:371-6. [PMID: 8963133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
There is currently public discussion as to whether the legal limit of blood alcohol concentration of drivers might be reduced from 0.8% to 0.5%. To acquire information concerning this problem, we measured temporal parameters of saccades and analysed the overall eye-movement behaviour with various blood ethanol concentrations. Eye movements were registered with an IR eye tracker and analysed while the subjects followed a randomly moving stimulus on a CRT screen and during presentation of a realistic traffic scene of 4 min duration on a TV screen. Alcohol has a significant effect on latency, velocity and accuracy of saccades, even at low concentrations between 0.4% and 0.6%. Because of the altered "gaze activity", the inflow of visual information is reduced in a state of inebriation. Our results are a further argument for reducing the legal limit of blood alcohol concentration to 0.5%.
Collapse
Affiliation(s)
- A Buser
- Augenklinik, Universität München
| | | | | | | | | |
Collapse
|
32
|
Lachenmayr B, Buser A, Müller S. [What visual information does the automobile driver need for safe driving in street traffic?]. Ophthalmologe 1994; 91:383-94. [PMID: 8086759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
In daytime traffic the driver experiences a tremendous input of visual information: His problem is to extract the relevant stimuli in order to have an adequate reaction. Traffic at dusk or nighttime, however, is characterized by the fact that even a driver with full visual function approaches his physiological limit. By assessing real traffic situations under various circumstances of weather and illumination (daytime, dusk, nighttime, city traffic, country road) limits of adaptation luminance, object size, object contrast and color are demonstrated. In addition, typical distributions of luminance in the visual field of the driver and the distributions of size and location of relevant objects are quantified. For glare situations typical values of glare angle and corneal illuminance of the glare light and the induced reduction of contrast are determined. Our data demonstrate the type of visual information required by the driver in order to drive safely in road traffic. These data allow conclusions to be made with respect to minimum requirements of visual function for car drivers.
Collapse
Affiliation(s)
- B Lachenmayr
- Arbeitsgruppe Psychophysik und Physiologische Optik, Universität München
| | | | | |
Collapse
|
33
|
Lachenmayr B, Buser A. [Limitation of lens power in automobile drivers]. Klin Monbl Augenheilkd 1994; 204:37-43. [PMID: 8152195 DOI: 10.1055/s-2008-1035500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
High plus lenses may cause defects in the peripheral visual field. Simple full vision lenses or lenticular lenses without a masked transition zone caused an absolute ring scotoma in the mid-periphery. Patients who were glasses of this type cannot see well enough to drive safely. Although modern edge finishes with masking of the transition zone reduce this problem, visual disturbances in the periphery of the lenses cannot be completely eliminated. A recommendation recently issued by the German Ophthalmological Society concerning maximum lens powers for motorists is aimed at preventing visual field defects of this type.
Collapse
|
34
|
Wacker J, Buser A, Lachenmayr BJ. Influence of stimulus size and contrast on the temporal parameters of saccadic eye movements: implications for road traffic. Ger J Ophthalmol 1993; 2:246-50. [PMID: 8220107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Saccadic eye movements are required for the recognition of peripheral objects in road traffic. Their latencies largely determine reaction time in emergency situations. The aim of this study was to investigate the influence of stimulus and surround parameters on the temporal characteristics of saccadic eye movements under conditions of object size, contrast and luminance corresponding to nighttime traffic. Square stimuli of 1 degree or 5 degrees size were presented under an eccentricity of 5 degrees and 15 degrees. The luminance of the surround was 4 x 10(-4) cd/m2 and 1 cd/m2. More than approx. 2,000 saccades of 7 normal subjects were registered and evaluated with respect to the latency, maximal velocity, and frequency of secondary saccades. At high stimulus contrast, latency approaches a minimum of approx. 200 ms. Latency increases with decreasing contrast up to maximal values of more than 600 ms. Transforming the contrast values into a relative decibel scale shows that this increase in latency occurs at significantly higher relative contrast values under scotopic as compared with photopic conditions. Our results demonstrate that an overall latency of 200-300 ms is not adequate for the assessment of accidents, especially under the stimulus conditions of nighttime traffic.
Collapse
Affiliation(s)
- J Wacker
- Augenklinik der Universität, München, Germany
| | | | | |
Collapse
|